I earned my doctorate in Medicinal Chemistry from Pune University in 1984 and completed postdoctoral studies in Biotechnology at the University of Wisconsin, Madison, USA, in 1987. Returning to India, I joined Standard Organics Limited (SOL) as Manager of R&D and established new research facilities focused on developing innovative technologies for manufacturing APIs, training a team of 25–30 chemists from top universities. Under my leadership, SOL became a leading API manufacturer, introducing isoxazole-based antibiotics for the first time in India, successfully commercializing Cloxacillin, Dicloxacillin, Flucloxacillin, and Oxacillin sodium, achieving global leadership within two years.

​

Recognizing the critical enzyme dependency in antibiotic production, I collaborated with Boehringer Mannheim, Germany, to optimize enzyme efficiency and reduce costs, significantly improving international competitiveness. SOL also became the sole supplier of Diclofenac Sodium to Ciba-Geigy, earning multiple Best Exporter Awards. Promoted to Director R&D in 1992, I guided a team of 100 in R&D and over 2,000 production staff, scaling operations to global standards.

​

In 1993, I co-founded Applied Research Centre, developing Sulbactam, Fluconazole, and Trichloro Salicylic Acid (TCSA), establishing manufacturing agreements with multiple Indian and international partners, and eventually founding Erythro Pharma Private Limited and Enpiar Pharma Private Limited. These facilities became preferred suppliers for Centaur Pharmaceuticals and Civenti Chem, USA, while supporting multiple startups and short-term manufacturing projects.

​

Erythro Pharma has also partnered with Medchem Source Seattle to develop a product for artificial lighting, and with American Bio Innovations, USA, to manufacture cell culture media and biosimilars for India and Southeast Asia. Collaborations with the University of Toronto target affordable treatments for mental health.

Currently, we are establishing a 200-acre state-of-the-art greenfield API manufacturing facility in Andhra Pradesh, designed to US FDA standards, powered by solar energy. Guided by decades of practical experience, this facility will support the company’s anticipated growth and expand our capacity to develop and manufacture innovative pharmaceutical solutions over the next two decades.